Skip to content

Schering-Plough SGP Operating Cash Flow

Operating Cash Flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.51B-39.8%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$1.08B+3.2%
Glaukos logo
GlaukosGKOS
-$12.53M+32.4%
AbbVie logo
AbbVieABBV
$3.83B+134%
Bausch + Lomb logo
Bausch + LombBLCO
$32M+228%
HRO
HarrowHROW
-$8.99M-146%

Other financials

Income statement

See full
Operating income-$15.4M-108%
Net income-$13.8M-56.6%
EPS (diluted)-$0.69+82.6%

Balance sheet

See full
Cash & equivalents$238.9M+312%
Total debt$1.6M
Total equity$250.1M+463%
Total assets$258.4M

Cash flow

See full
CapEx$676.0K+312%
Free cash flow-$14.2M-70.0%

Valuation

See full
Market cap$744.23M-23.4%
Enterprise value$506.93M

Returns & leverage

See full
Return on equity-34.3%
Debt / equity
Current ratio38×

Where this comes from

Reported directly by Schering-Plough in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Schering-Plough’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schering-Plough's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schering-Plough's operating cash flow?
Schering-Plough (SGP) reported operating cash flow of -$13.54M in Q1 2026.
How has Schering-Plough's operating cash flow changed year-over-year?
Schering-Plough's operating cash flow decreased by 65.2% year-over-year, from -$8.2M to -$13.54M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.